C.M. Bidwell & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,400
Closed -$403K 462
2017
Q4
$403K Buy
+5,400
New +$345K 0.35% 86
2016
Q4
Sell
-50,245
Closed -$3.54M 335
2016
Q3
$3.54M Sell
50,245
-51,080
-50% -$3.82M 0.84% 73
2016
Q2
$7.68M Buy
101,325
+97,700
+2,695% +$7.18M 1.91% 6
2016
Q1
$249K Sell
3,625
-87,875
-96% -$6.32M 0.06% 145
2015
Q4
$8M Buy
91,500
+210
+0.2% +$18K 1.9% 8
2015
Q3
$7.39M Buy
91,290
+87,515
+2,318% +$7.62M 1.82% 12
2015
Q2
$336K Buy
+3,775
New +$330K 0.08% 125

Other funds holding ESRX

C.M. Bidwell & Associates's ESRX Position: Q1 2018 in Review

C.M. Bidwell & Associates sold out of Express Scripts Holding Company (ESRX) in Q1 2018, closing a stake of 5,400 shares — an estimated $403K sold.

C.M. Bidwell & Associates first reported a position in ESRX in Q2 2015 and held it in 7 quarters. The position peaked at $8M in Q4 2015. 1,119 funds tracked by Wall St. Rank hold ESRX as of Q1 2018.

  • C.M. Bidwell & Associates reported no remaining Express Scripts Holding Company position as of Q1 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 5,400 Express Scripts Holding Company shares in Q1 2018, an estimated $403K.
  • C.M. Bidwell & Associates first reported a position in Express Scripts Holding Company in Q2 2015 and held it in 7 quarters.
  • C.M. Bidwell & Associates's Express Scripts Holding Company position peaked at $8M in Q4 2015.
  • 1,119 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2018, filed 11 May 2018.